Sodium aceneuramateAlternative Names: KI-111; Mucopic
Latest Information Update: 06 Jun 2001
At a glance
- Originator MECT Corporation
- Class Antitussives; Expectorants
- Mechanism of Action
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- No development reported Cough
Most Recent Events
- 06 Jun 2001 No-Development-Reported for Cough in Japan (Inhalation)